Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Sep-30-18 | Sep-30-16 |
| Revenues | 527.2 | 311.3 | 15.4 | 12.7 | 12.7 |
| Revenue growth | 69.3% | 1921.8% | | | |
| Cost of goods sold | 37.5 | 27.2 | 6.6 | 6.0 | 3.8 |
| Gross profit | 489.7 | 284.1 | 8.8 | 6.8 | 8.9 |
| Gross margin | 92.9% | 91.3% | 56.9% | 53.0% | 70.0% |
| Selling, general and administrative | 336.0 | 259.9 | 165.7 | 141.8 | 33.2 |
| Research and development | 205.4 | 142.7 | | 153.7 | 104.4 |
| EBIT | -51.8 | -118.4 | -303.6 | -288.8 | -128.7 |
| EBIT margin | -9.8% | -38.0% | -1971.6% | -2267.4% | -1010.6% |
| Pre-tax income | -55.0 | -9.2 | -305.4 | -291.4 | -92.4 |
| Income taxes | 3.1 | -0.2 | -0.2 | 3.8 | -0.7 |
| Tax rate | | 2.0% | 0.1% | | 0.8% |
| Net income | -58.1 | -9.0 | -305.3 | -295.2 | -91.7 |
| Net margin | -11.0% | -2.9% | -1982.3% | -2317.4% | -720.3% |
| |
| Diluted EPS | ($0.15) | ($0.02) | ($0.88) | ($0.88) | ($0.34) |
| Shares outstanding (diluted) | 375.6 | 371.6 | 347.1 | 333.9 | 272.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|